Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Serrano-Candelas

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Molecular Oncology|June 10, 2018
Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growthEva Serrano-Candelas, Erola Ainsua-Enrich, Arnau Navinés-Ferrer, et al.
Carcinogenesis|May 31, 2022
The PxIxIT motif of the RCAN3 inhibits angiogenesis and tumor progression in Triple Negative breast cancer in immunocompetent miceAtilla Biçer, Patricia López-Henares, Marta Molero-Magariño, et al.
Carcinogenesis|April 29, 2015
A novel role for an RCAN3-derived peptide as a tumor suppressor in breast cancerSergio Martínez-Høyer, Sònia Solé-Sánchez, Fernando Aguado, et al.
International Journal of Molecular Sciences|February 15, 2022
Identification of NLRP3<sup>PYD</sup> Homo-Oligomerization Inhibitors with Anti-Inflammatory ActivitySoroush Moasses Ghafary, Paula M Soriano-Teruel, Shima Lotfollahzadeh, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 24, 2024
Corrigendum to "Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support" [Biomed. Pharmacother. 174 (2024) 116530]Marta Moreno-Torres, Ernesto López-Pascual, Anna Rapisarda, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 4, 2024
Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning supportMarta Moreno-Torres, Ernesto López-Pascual, Anna Rapisarda, et al.
Environmental Toxicology and Chemistry|February 12, 2025
Addressing the challenges of acute toxicity hazard classification using a non-animal defined approachDonna S Macmillan, Pravin Ambure, Vicente Aranda, et al.
Frontiers in Cell and Developmental Biology|January 22, 2024
An extensive review on phenolic compounds and their potential estrogenic properties on skin physiologyFrancesca Rispo, Giulia De Negri Atanasio, Ilaria Demori, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Molecular Oncology|June 10, 2018
Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growthEva Serrano-Candelas, Erola Ainsua-Enrich, Arnau Navinés-Ferrer, et al.
Carcinogenesis|May 31, 2022
The PxIxIT motif of the RCAN3 inhibits angiogenesis and tumor progression in Triple Negative breast cancer in immunocompetent miceAtilla Biçer, Patricia López-Henares, Marta Molero-Magariño, et al.
Carcinogenesis|April 29, 2015
A novel role for an RCAN3-derived peptide as a tumor suppressor in breast cancerSergio Martínez-Høyer, Sònia Solé-Sánchez, Fernando Aguado, et al.
International Journal of Molecular Sciences|February 15, 2022
Identification of NLRP3<sup>PYD</sup> Homo-Oligomerization Inhibitors with Anti-Inflammatory ActivitySoroush Moasses Ghafary, Paula M Soriano-Teruel, Shima Lotfollahzadeh, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 24, 2024
Corrigendum to "Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support" [Biomed. Pharmacother. 174 (2024) 116530]Marta Moreno-Torres, Ernesto López-Pascual, Anna Rapisarda, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 4, 2024
Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning supportMarta Moreno-Torres, Ernesto López-Pascual, Anna Rapisarda, et al.
Environmental Toxicology and Chemistry|February 12, 2025
Addressing the challenges of acute toxicity hazard classification using a non-animal defined approachDonna S Macmillan, Pravin Ambure, Vicente Aranda, et al.
Frontiers in Cell and Developmental Biology|January 22, 2024
An extensive review on phenolic compounds and their potential estrogenic properties on skin physiologyFrancesca Rispo, Giulia De Negri Atanasio, Ilaria Demori, et al.
Pageof 5